Black Jeffrey G.
Known title: Chief Financial OfficerCIK: 0001449439
Black Jeffrey G.'s purchase track record
Black Jeffrey G. has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/15/2024 | XGN | $66K | +41.9% | +101.7% | +1.5% |
| 5/18/2023 | LAB | $194K | +24.2% | +0.5% | +7.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| XGN | ▼ Sell | Open Market | 20,614 | $149K | 9/1/2026 | View on chart |
| XGN | ▲ Buy | Grant | 1,571 | $5K | 9/1/2026 | View on chart |
| XGN | ▲ Buy | Grant | 75,000 | $237K | 3/12/2026 | View on chart |
| XGN | ▲ Buy | Grant | 1,511 | $5K | 2/27/2026 | View on chart |
| XGN | ▼ Sell | Open Market | 1,584 | $6K | 2/24/2026 | View on chart |
| XGN | ▼ Sell | Open Market | 20,466 | $200K | 9/2/2025 | View on chart |
| XGN | ▲ Buy | Grant | 15,000 | $0 | 2/21/2025 | View on chart |
| XGN | ▲ Buy | Open Market | 22,298 | $66K | 11/15/2024 | View on chart |
| XGN | ▲ Buy | Grant | 225,000 | $0 | 9/1/2024 | View on chart |
| LAB | ▼ Sell | Tax Withholding | 6,690 | $13K | 8/20/2024 | View on chart |
| LAB | ▲ Buy | Option Exercise | 13,157 | $0 | 8/15/2024 | View on chart |
| LAB | ▼ Sell | Tax Withholding | 4,695 | $7K | 8/15/2024 | View on chart |
| LAB | ▲ Buy | Grant | 300,000 | $0 | 5/20/2024 | View on chart |
| LAB | ▲ Buy | Option Exercise | 52,631 | $0 | 5/15/2024 | View on chart |
| LAB | ▼ Sell | Tax Withholding | 18,779 | $48K | 5/15/2024 | View on chart |
| LAB | ▲ Buy | Open Market | 42,492 | $97K | 5/19/2023 | View on chart |
| LAB | ▲ Buy | Open Market | 43,492 | $96K | 5/18/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
TD Cowen Raises Exagen Price Target to $11
TD Cowen has maintained its positive stance on Exagen, raising its price target to $11. This update aligns with the broader analyst consensus, where the average target sits at $10.14. The move provides context for the stock's current position within its 52-week range of $2.59 to $12.23.
TD Cowen Raises Exagen Price Target to $11. TD Cowen has maintained its positive stance on Exagen, raising its price target to $11. This update aligns with the broader analyst consensus, where the average target sits at $10.14. The move provides context for the stock's current position within its 52-week range of $2.59 to $12.23.